© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
September 28, 2022
Drs Chopra and Feuerstadt summarize challenges with current treatments and discuss live biotherapeutic products that are being studied for recurrent C difficile infection (rCDI).
Dr Lodise summarizes foundational trials that led to the use of fecal microbiota transplant for the treatment of rCDI.
September 21, 2022
Dr Teena Chopra shares her approach to monitoring patients with C difficile infection (CDI).
Drs Tom Lodise and Bincy Abraham provide an overview of fecal microbiota transplantation and long-term safety of FMT use.
FDA Approves Dupilumab as the First Medical Treatment for Prurigo Nodularis
Dupilumab Leads to Favorable Outcomes for Chronic Rhinosinusitis
Review Examines Different Ways to Reduce Costs for Atopic Dermatitis Treatment